CINXE.COM

<!DOCTYPE html> <html lang="en" dir="ltr"> <head>  <script async src="https://www.googletagmanager.com/gtag/js?id=G-P63WKM1TM1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-P63WKM1TM1'); </script>  <script type="text/javascript" > (function(m,e,t,r,i,k,a){m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)}; m[i].l=1*new Date(); for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }} k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a)}) (window, document, "script", "https://mc.yandex.ru/metrika/tag.js", "ym"); ym(55165297, "init", { clickmap:false, trackLinks:true, accurateTrackBounce:true, webvisor:false }); </script> <noscript><div><img src="https://mc.yandex.ru/watch/55165297" style="position:absolute; left:-9999px;" alt="" /></div></noscript>    <title>Search results for: glaucoma</title> <meta name="description" content="Search results for: glaucoma"> <meta name="keywords" content="glaucoma"> <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=1, user-scalable=no"> <meta charset="utf-8"> <link href="https://cdn.waset.org/favicon.ico" type="image/x-icon" rel="shortcut icon"> <link href="https://cdn.waset.org/static/plugins/bootstrap-4.2.1/css/bootstrap.min.css" rel="stylesheet"> <link href="https://cdn.waset.org/static/plugins/fontawesome/css/all.min.css" rel="stylesheet"> <link href="https://cdn.waset.org/static/css/site.css?v=150220211555" rel="stylesheet"> </head> <body> <header> <div class="container"> <nav class="navbar navbar-expand-lg navbar-light"> <a class="navbar-brand" href="https://waset.org"> <img src="https://cdn.waset.org/static/images/wasetc.png" alt="Open Science Research Excellence" title="Open Science Research Excellence" /> </a> <button class="d-block d-lg-none navbar-toggler ml-auto" type="button" data-toggle="collapse" data-target="#navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button> <div class="w-100"> <div class="d-none d-lg-flex flex-row-reverse"> <form method="get" action="https://waset.org/search" class="form-inline my-2 my-lg-0"> <input class="form-control mr-sm-2" type="search" placeholder="Search Conferences" value="glaucoma" name="q" aria-label="Search"> <button class="btn btn-light my-2 my-sm-0" type="submit"><i class="fas fa-search"></i></button> </form> </div> <div class="collapse navbar-collapse mt-1" id="navbarMenu"> <ul class="navbar-nav ml-auto align-items-center" id="mainNavMenu"> <li class="nav-item"> <a class="nav-link" href="https://waset.org/conferences" title="Conferences in 2024/2025/2026">Conferences</a> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/disciplines" title="Disciplines">Disciplines</a> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/committees" rel="nofollow">Committees</a> </li> <li class="nav-item dropdown"> <a class="nav-link dropdown-toggle" href="#" id="navbarDropdownPublications" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> Publications </a> <div class="dropdown-menu" aria-labelledby="navbarDropdownPublications"> <a class="dropdown-item" href="https://publications.waset.org/abstracts">Abstracts</a> <a class="dropdown-item" href="https://publications.waset.org">Periodicals</a> <a class="dropdown-item" href="https://publications.waset.org/archive">Archive</a> </div> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/page/support" title="Support">Support</a> </li> </ul> </div> </div> </nav> </div> </header> <main> <div class="container mt-4"> <div class="row"> <div class="col-md-9 mx-auto"> <form method="get" action="https://publications.waset.org/abstracts/search"> <div id="custom-search-input"> <div class="input-group"> <i class="fas fa-search"></i> <input type="text" class="search-query" name="q" placeholder="Author, Title, Abstract, Keywords" value="glaucoma"> <input type="submit" class="btn_search" value="Search"> </div> </div> </form> </div> </div> <div class="row mt-3"> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Commenced</strong> in January 2007</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Frequency:</strong> Monthly</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Edition:</strong> International</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Paper Count:</strong> 53</div> </div> </div> </div> <h1 class="mt-3 mb-3 text-center" style="font-size:1.6rem;">Search results for: glaucoma</h1> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">53</span> Ologen Collagen Matrix Implant in Uveitis Induced Glaucoma with Temporal Trabeculectomy</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ritesh%20Verma">Ritesh Verma</a>, <a href="https://publications.waset.org/abstracts/search?q=Manisha%20Rathi"> Manisha Rathi</a>, <a href="https://publications.waset.org/abstracts/search?q=Chand%20Singh%20Dhull"> Chand Singh Dhull</a>, <a href="https://publications.waset.org/abstracts/search?q=Sumit%20Sachdeva"> Sumit Sachdeva</a>, <a href="https://publications.waset.org/abstracts/search?q=Jitender%20Phogat"> Jitender Phogat</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Temporal trabeculectomy with the Ologen implant was done in a 66-year-old lady with uveitic glaucoma. Serial IOP measurement was done to assess the efficacy of ologen implant in uveitic glaucoma. The patient had an IOP of 4mmhg day 1 postoperatively and Ologen implant was in place with a well-formed bleb. On follow up patient had an IOP of 14mmhg and unaided visual acuity of 6/12 on day 10 postoperatively. After 12 weeks of Trabeculectomy with Ologen implant, the IOP of the patient was 14 mmHg, the vision was 6/6 with -1.25 DS and -1.25 DC at 90 degrees. Trabeculectomy performed in patients with uveitic glaucoma has a higher chance of failure due to increased inflammation and fibrosis. Trabeculectomy with ologen implant done in a patient of uveitic glaucoma provides excellent postoperative results and the patient has a well-controlled IOP even after 56 weeks of surgery and a best corrected visual acuity of 6/6. Trabeculectomy with the ologen implant is superior to other surgeries in cases of secondary glaucoma with increased inflammation. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma%20surgery" title="glaucoma surgery">glaucoma surgery</a>, <a href="https://publications.waset.org/abstracts/search?q=ologen%20implant" title=" ologen implant"> ologen implant</a>, <a href="https://publications.waset.org/abstracts/search?q=temporal%20trabeculectomy" title=" temporal trabeculectomy"> temporal trabeculectomy</a>, <a href="https://publications.waset.org/abstracts/search?q=uveitic%20glaucoma" title=" uveitic glaucoma"> uveitic glaucoma</a> </p> <a href="https://publications.waset.org/abstracts/84549/ologen-collagen-matrix-implant-in-uveitis-induced-glaucoma-with-temporal-trabeculectomy" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/84549.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">211</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">52</span> Genetic Association of SIX6 Gene with Pathogenesis of Glaucoma</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Riffat%20Iqbal">Riffat Iqbal</a>, <a href="https://publications.waset.org/abstracts/search?q=Sidra%20Ihsan"> Sidra Ihsan</a>, <a href="https://publications.waset.org/abstracts/search?q=Andleeb%20Batool"> Andleeb Batool</a>, <a href="https://publications.waset.org/abstracts/search?q=Maryam%20Mukhtar"> Maryam Mukhtar</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma is a gathering of optic neuropathies described by dynamic degeneration of retinal ganglionic cells. It is clinically and innately heterogenous illness containing a couple of particular forms each with various causes and severities. Primary open-angle glaucoma (POAG) is the most generally perceived kind of glaucoma. This study investigated the genetic association of single nucleotide polymorphisms (SNPs; rs10483727 and rs33912345) at the SIX1/SIX6 locus with primary open-angle glaucoma (POAG) in the Pakistani population. The SIX6 gene plays an important role in ocular development and has been associated with morphology of the optic nerve. A total of 100 patients clinically diagnosed with glaucoma and 100 control individuals of age over 40 were enrolled in the study. Genomic DNA was extracted by organic extraction method. The SNP genotyping was done by (i) PCR based restriction fragment length polymorphism (RFLP) and sequencing method. Significant genetic associations were observed for rs10483727 (risk allele T) and rs33912345 (risk allele C) with POAG. Hence, it was concluded that Six6 gene is genetically associated with pathogenesis of Glaucoma in Pakistan. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=genotyping" title="genotyping">genotyping</a>, <a href="https://publications.waset.org/abstracts/search?q=Pakistani%20population" title=" Pakistani population"> Pakistani population</a>, <a href="https://publications.waset.org/abstracts/search?q=primary%20open-angle%20glaucoma" title=" primary open-angle glaucoma"> primary open-angle glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=SIX6%20gene" title=" SIX6 gene"> SIX6 gene</a> </p> <a href="https://publications.waset.org/abstracts/102183/genetic-association-of-six6-gene-with-pathogenesis-of-glaucoma" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/102183.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">184</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">51</span> Importance of Developing a Decision Support System for Diagnosis of Glaucoma</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Murat%20Durucu">Murat Durucu</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma is a condition of irreversible blindness, early diagnosis and appropriate interventions to make the patients able to see longer time. In this study, it addressed that the importance of developing a decision support system for glaucoma diagnosis. Glaucoma occurs when pressure happens around the eyes it causes some damage to the optic nerves and deterioration of vision. There are different levels ranging blindness of glaucoma disease. The diagnosis at an early stage allows a chance for therapies that slows the progression of the disease. In recent years, imaging technology from Heidelberg Retinal Tomography (HRT), Stereoscopic Disc Photo (SDP) and Optical Coherence Tomography (OCT) have been used for the diagnosis of glaucoma. This better accuracy and faster imaging techniques in response technique of OCT have become the most common method used by experts. Although OCT images or HRT precision and quickness, especially in the early stages, there are still difficulties and mistakes are occurred in diagnosis of glaucoma. It is difficult to obtain objective results on diagnosis and placement process of the doctor's. It seems very important to develop an objective decision support system for diagnosis and level the glaucoma disease for patients. By using OCT images and pattern recognition systems, it is possible to develop a support system for doctors to make their decisions on glaucoma. Thus, in this recent study, we develop an evaluation and support system to the usage of doctors. Pattern recognition system based computer software would help the doctors to make an objective evaluation for their patients. It is intended that after development and evaluation processes of the software, the system is planning to be serve for the usage of doctors in different hospitals. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=decision%20support%20system" title="decision support system">decision support system</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=image%20processing" title=" image processing"> image processing</a>, <a href="https://publications.waset.org/abstracts/search?q=pattern%20recognition" title=" pattern recognition"> pattern recognition</a> </p> <a href="https://publications.waset.org/abstracts/54286/importance-of-developing-a-decision-support-system-for-diagnosis-of-glaucoma" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/54286.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">302</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">50</span> Ophthalmic Hashing Based Supervision of Glaucoma and Corneal Disorders Imposed on Deep Graphical Model</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=P.%20S.%20Jagadeesh%20Kumar">P. S. Jagadeesh Kumar</a>, <a href="https://publications.waset.org/abstracts/search?q=Yang%20Yung"> Yang Yung</a>, <a href="https://publications.waset.org/abstracts/search?q=Mingmin%20Pan"> Mingmin Pan</a>, <a href="https://publications.waset.org/abstracts/search?q=Xianpei%20Li"> Xianpei Li</a>, <a href="https://publications.waset.org/abstracts/search?q=Wenli%20Hu"> Wenli Hu</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma is impelled by optic nerve mutilation habitually represented as cupping and visual field injury frequently with an arcuate pattern of mid-peripheral loss, subordinate to retinal ganglion cell damage and death. Glaucoma is the second foremost cause of blindness and the chief cause of permanent blindness worldwide. Consequently, all-embracing study into the analysis and empathy of glaucoma is happening to escort deep learning based neural network intrusions to deliberate this substantial optic neuropathy. This paper advances an ophthalmic hashing based supervision of glaucoma and corneal disorders preeminent on deep graphical model. Ophthalmic hashing is a newly proposed method extending the efficacy of visual hash-coding to predict glaucoma corneal disorder matching, which is the faster than the existing methods. Deep graphical model is proficient of learning interior explications of corneal disorders in satisfactory time to solve hard combinatoric incongruities using deep Boltzmann machines. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=corneal%20disorders" title="corneal disorders">corneal disorders</a>, <a href="https://publications.waset.org/abstracts/search?q=deep%20Boltzmann%20machines" title=" deep Boltzmann machines"> deep Boltzmann machines</a>, <a href="https://publications.waset.org/abstracts/search?q=deep%20graphical%20model" title=" deep graphical model"> deep graphical model</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=neural%20networks" title=" neural networks"> neural networks</a>, <a href="https://publications.waset.org/abstracts/search?q=ophthalmic%20hashing" title=" ophthalmic hashing"> ophthalmic hashing</a> </p> <a href="https://publications.waset.org/abstracts/78678/ophthalmic-hashing-based-supervision-of-glaucoma-and-corneal-disorders-imposed-on-deep-graphical-model" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/78678.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">250</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">49</span> Comparison of Central Light Reflex Width-to-Retinal Vessel Diameter Ratio between Glaucoma and Normal Eyes by Using Edge Detection Technique </h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=P.%20Siriarchawatana">P. Siriarchawatana</a>, <a href="https://publications.waset.org/abstracts/search?q=K.%20Leungchavaphongse"> K. Leungchavaphongse</a>, <a href="https://publications.waset.org/abstracts/search?q=N.%20Covavisaruch"> N. Covavisaruch</a>, <a href="https://publications.waset.org/abstracts/search?q=K.%20Rojananuangnit"> K. Rojananuangnit</a>, <a href="https://publications.waset.org/abstracts/search?q=P.%20Boondaeng"> P. Boondaeng</a>, <a href="https://publications.waset.org/abstracts/search?q=N.%20Panyayingyong"> N. Panyayingyong</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma is a disease that causes visual loss in adults. Glaucoma causes damage to the optic nerve and its overall pathophysiology is still not fully understood. Vasculopathy may be one of the possible causes of nerve damage. Photographic imaging of retinal vessels by fundus camera during eye examination may complement clinical management. This paper presents an innovation for measuring central light reflex width-to-retinal vessel diameter ratio (CRR) from digital retinal photographs. Using our edge detection technique, CRRs from glaucoma and normal eyes were compared to examine differences and associations. CRRs were evaluated on fundus photographs of participants from Mettapracharak (Wat Raikhing) Hospital in Nakhon Pathom, Thailand. Fifty-five photographs from normal eyes and twenty-one photographs from glaucoma eyes were included. Participants with hypertension were excluded. In each photograph, CRRs from four retinal vessels, including arteries and veins in the inferotemporal and superotemporal regions, were quantified using edge detection technique. From our finding, mean CRRs of all four retinal arteries and veins were significantly higher in persons with glaucoma than in those without glaucoma (0.34 <em>vs</em>. 0.32, <em>p</em> < 0.05 for inferotemporal vein, 0.33 <em>vs</em>. 0.30, <em>p</em> < 0.01 for inferotemporal artery, 0.34 <em>vs</em>. 0.31, <em>p </em>< 0.01 for superotemporal vein, and 0.33 <em>vs</em>. 0.30, <em>p</em> < 0.05 for superotemporal artery). From these results, an increase in CRRs of retinal vessels, as quantitatively measured from fundus photographs, could be associated with glaucoma. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title="glaucoma">glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=retinal%20vessel" title=" retinal vessel"> retinal vessel</a>, <a href="https://publications.waset.org/abstracts/search?q=central%20light%20reflex" title=" central light reflex"> central light reflex</a>, <a href="https://publications.waset.org/abstracts/search?q=image%20processing" title=" image processing"> image processing</a>, <a href="https://publications.waset.org/abstracts/search?q=fundus%20photograph" title=" fundus photograph"> fundus photograph</a>, <a href="https://publications.waset.org/abstracts/search?q=edge%20detection" title=" edge detection"> edge detection</a> </p> <a href="https://publications.waset.org/abstracts/54545/comparison-of-central-light-reflex-width-to-retinal-vessel-diameter-ratio-between-glaucoma-and-normal-eyes-by-using-edge-detection-technique" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/54545.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">325</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">48</span> The Role of NAD+ and Nicotinamide (Vitamin B3) in Glaucoma: A Literature Review</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=James%20Pietris">James Pietris</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma is a collection of irreversible optic neuropathies which, if left untreated, lead to severe visual field loss. These diseases are a leading cause of blindness across the globe and are estimated to affect approximately 80 million people, particularly women and people of Asian descent.1This represents a major burden on healthcare systems worldwide. Recently, there has been increasing interest in the potential of nicotinamide (vitamin B3) as a novel option in the management of glaucoma. This review aims to analyse the currently available literature to determine whether there is evidence of an association between nicotinamide adenine dinucleotide (NAD+) and glaucomatous optic neuropathy and whether nicotinamide has the potential to prevent or reverse these effects. The literature showed a strong connection between reduced NAD+ levels and retinal ganglion cell dysfunction through multiple different studies. There is also evidence of the positive effect of nicotinamide supplementation on retinal ganglion cell function in models of mouse glaucoma and in a study involving humans. Based on the literature findings, a recommendation has been made that more research into the efficacy, appropriate dosing, and potential side effects of nicotinamide supplementation is needed before it can be definitively determined whether it is appropriate for widespread prophylactic and therapeutic use against glaucoma in humans. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title="glaucoma">glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=nicotinamide" title=" nicotinamide"> nicotinamide</a>, <a href="https://publications.waset.org/abstracts/search?q=vitamin%20B3" title=" vitamin B3"> vitamin B3</a>, <a href="https://publications.waset.org/abstracts/search?q=optic%20neuropathy" title=" optic neuropathy"> optic neuropathy</a> </p> <a href="https://publications.waset.org/abstracts/148274/the-role-of-nad-and-nicotinamide-vitamin-b3-in-glaucoma-a-literature-review" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/148274.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">106</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">47</span> Impact of Glaucoma Surgery on Corneal Endothelium</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Majid%20Moshirfar">Majid Moshirfar</a>, <a href="https://publications.waset.org/abstracts/search?q=Kyle%20Margulies"> Kyle Margulies</a>, <a href="https://publications.waset.org/abstracts/search?q=Yasmyne%20C.%20Ronquillo"> Yasmyne C. Ronquillo</a>, <a href="https://publications.waset.org/abstracts/search?q=Phillip%20Hoopes"> Phillip Hoopes</a> </p> <p class="card-text"><strong>Abstract:</strong></p> A total of 66 articles were reviewed to compare glaucoma and its associated surgeries' effect on central corneal endothelium cell density (CECD). The paper reports the average reported central CECD loss at 3-, 6-, 12-, 24-, 36-, 48-, and 60-month post-operation for each glaucoma surgery. ALT, MLT, SLT, CS AGV, VC BGI, Hydrus + phaco, XEN gel + phaco, PRESERFLO, Dual iStent, or Trabectome had no significant impact on postoperative CECD compared to either preoperative CECD or control group CECD. The highest CECD loss was found to be EXPRESS-phaco, AC AGV, CS BGI, CS BGI, AC BGI, and AC BGI at the 3-, 6-, 12-, 24-, 36-, 48-, and 60-month follow-ups, respectively. AC AGV, Trab + MMC, Trab, AC BGI, Trab + MMC, Cypass, and Cypass showed the smallest reduction of CECD at the 3-, 6-, 12-, 24-, 36-, 48-, and 60-month follow-ups. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title="glaucoma">glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=corneal%20endothelium" title=" corneal endothelium"> corneal endothelium</a>, <a href="https://publications.waset.org/abstracts/search?q=cell%20density" title=" cell density"> cell density</a>, <a href="https://publications.waset.org/abstracts/search?q=surgery%20outcome" title=" surgery outcome"> surgery outcome</a> </p> <a href="https://publications.waset.org/abstracts/156756/impact-of-glaucoma-surgery-on-corneal-endothelium" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/156756.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">99</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">46</span> The Clinical Use of Ahmed Valve Implant as an Aqueous Shunt for Control of Uveitic Glaucoma in Dogs</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Khaled%20M.%20Ali">Khaled M. Ali</a>, <a href="https://publications.waset.org/abstracts/search?q=M.%20A.%20Abdel-Hamid"> M. A. Abdel-Hamid</a>, <a href="https://publications.waset.org/abstracts/search?q=Ayman%20A.%20Mostafa"> Ayman A. Mostafa</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Objective: Safety and efficacy of Ahmed glaucoma valve implantation for the management of uveitis induced glaucoma evaluated on the five dogs with uncontrollable glaucoma. Materials and Methods: Ahmed Glaucoma Valve (AGV®; New World Medical, Rancho Cucamonga, CA, USA) is a flow restrictive, non-obstructive self-regulating valve system. Preoperative ocular evaluation included direct ophthalmoscopy and measurement of the intraocular pressure (IOP). The implant was examined and primed prior to implantation. The selected site of the valve implantation was the superior quadrant between the superior and lateral rectus muscles. A fornix-based incision was made through the conjunectiva and Tenon’s capsule. A pocket is formed by blunt dissection of Tenon’s capsule from the episclera. The body of the implant was inserted into the pocket with the leading edge of the device around 8-10 mm from the limbus. Results: No post operative complications were detected in the operated eyes except a persistent corneal edema occupied the upper half of the cornea in one case. Hyphaema was very mild and seen only in two cases which resolved quickly two days after surgery. Endoscopical evaluation for the operated eyes revealed a normal ocular fundus with clearly visible optic papilla, tapetum and retinal blood vessels. No evidence of hemorrhage, infection, adhesions or retinal abnormalities was detected. Conclusion: Ahmed glaucoma valve is safe and effective implant for treatment of uveitic glaucoma in dogs. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ahmed%20valve" title="Ahmed valve">Ahmed valve</a>, <a href="https://publications.waset.org/abstracts/search?q=endoscopy" title=" endoscopy"> endoscopy</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=ocular%20fundus" title=" ocular fundus"> ocular fundus</a> </p> <a href="https://publications.waset.org/abstracts/37794/the-clinical-use-of-ahmed-valve-implant-as-an-aqueous-shunt-for-control-of-uveitic-glaucoma-in-dogs" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/37794.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">586</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">45</span> Support Vector Machine Based Retinal Therapeutic for Glaucoma Using Machine Learning Algorithm</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=P.%20S.%20Jagadeesh%20Kumar">P. S. Jagadeesh Kumar</a>, <a href="https://publications.waset.org/abstracts/search?q=Mingmin%20Pan"> Mingmin Pan</a>, <a href="https://publications.waset.org/abstracts/search?q=Yang%20Yung"> Yang Yung</a>, <a href="https://publications.waset.org/abstracts/search?q=Tracy%20Lin%20Huan"> Tracy Lin Huan</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma is a group of visual maladies represented by the scheduled optic nerve neuropathy; means to the increasing dwindling in vision ground, resulting in loss of sight. In this paper, a novel support vector machine based retinal therapeutic for glaucoma using machine learning algorithm is conservative. The algorithm has fitting pragmatism; subsequently sustained on correlation clustering mode, it visualizes perfect computations in the multi-dimensional space. Support vector clustering turns out to be comparable to the scale-space advance that investigates the cluster organization by means of a kernel density estimation of the likelihood distribution, where cluster midpoints are idiosyncratic by the neighborhood maxima of the concreteness. The predicted planning has 91% attainment rate on data set deterrent on a consolidation of 500 realistic images of resolute and glaucoma retina; therefore, the computational benefit of depending on the cluster overlapping system pedestal on machine learning algorithm has complete performance in glaucoma therapeutic. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=machine%20learning%20algorithm" title="machine learning algorithm">machine learning algorithm</a>, <a href="https://publications.waset.org/abstracts/search?q=correlation%20clustering%20mode" title=" correlation clustering mode"> correlation clustering mode</a>, <a href="https://publications.waset.org/abstracts/search?q=cluster%20overlapping%20system" title=" cluster overlapping system"> cluster overlapping system</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=kernel%20density%20estimation" title=" kernel density estimation"> kernel density estimation</a>, <a href="https://publications.waset.org/abstracts/search?q=retinal%20therapeutic" title=" retinal therapeutic"> retinal therapeutic</a> </p> <a href="https://publications.waset.org/abstracts/80153/support-vector-machine-based-retinal-therapeutic-for-glaucoma-using-machine-learning-algorithm" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/80153.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">254</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">44</span> Glaucoma Detection in Retinal Tomography Using the Vision Transformer</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Sushish%20Baral">Sushish Baral</a>, <a href="https://publications.waset.org/abstracts/search?q=Pratibha%20Joshi"> Pratibha Joshi</a>, <a href="https://publications.waset.org/abstracts/search?q=Yaman%20Maharjan"> Yaman Maharjan</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma is a chronic eye condition that causes vision loss that is irreversible. Early detection and treatment are critical to prevent vision loss because it can be asymptomatic. For the identification of glaucoma, multiple deep learning algorithms are used. Transformer-based architectures, which use the self-attention mechanism to encode long-range dependencies and acquire extremely expressive representations, have recently become popular. Convolutional architectures, on the other hand, lack knowledge of long-range dependencies in the image due to their intrinsic inductive biases. The aforementioned statements inspire this thesis to look at transformer-based solutions and investigate the viability of adopting transformer-based network designs for glaucoma detection. Using retinal fundus images of the optic nerve head to develop a viable algorithm to assess the severity of glaucoma necessitates a large number of well-curated images. Initially, data is generated by augmenting ocular pictures. After that, the ocular images are pre-processed to make them ready for further processing. The system is trained using pre-processed images, and it classifies the input images as normal or glaucoma based on the features retrieved during training. The Vision Transformer (ViT) architecture is well suited to this situation, as it allows the self-attention mechanism to utilise structural modeling. Extensive experiments are run on the common dataset, and the results are thoroughly validated and visualized. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title="glaucoma">glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=vision%20transformer" title=" vision transformer"> vision transformer</a>, <a href="https://publications.waset.org/abstracts/search?q=convolutional%20architectures" title=" convolutional architectures"> convolutional architectures</a>, <a href="https://publications.waset.org/abstracts/search?q=retinal%20fundus%20images" title=" retinal fundus images"> retinal fundus images</a>, <a href="https://publications.waset.org/abstracts/search?q=self-attention" title=" self-attention"> self-attention</a>, <a href="https://publications.waset.org/abstracts/search?q=deep%20learning" title=" deep learning"> deep learning</a> </p> <a href="https://publications.waset.org/abstracts/141224/glaucoma-detection-in-retinal-tomography-using-the-vision-transformer" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/141224.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">191</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">43</span> Surgical Treatment of Glaucoma – Literature and Video Review of Blebs, Tubes, and Micro-Invasive Glaucoma Surgeries (MIGS)</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ana%20Miguel">Ana Miguel</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Purpose: Glaucoma is the second cause of worldwide blindness and the first cause of irreversible blindness. Trabeculectomy, the standard glaucoma surgery, has a success rate between 36.0% and 98.0% at three years and a high complication rate, leading to the development of different surgeries, micro-invasive glaucoma surgeries (MIGS). MIGS devices are diverse and have various indications, risks, and effectiveness. We intended to review MIGS’ surgical techniques, indications, contra-indications, and IOP effect. Methods: We performed a literature review of MIGS to differentiate the devices and their reported effectiveness compared to traditional surgery (tubes and blebs). We also conducted a video review of the last 1000 glaucoma surgeries of the author (including MIGS, but also trabeculectomy, deep sclerectomy, and tubes of Ahmed and Baerveldt) performed at glaucoma and advanced anterior segment fellowship in Canada and France, to describe preferred surgical techniques for each. Results: We present the videos with surgical techniques and pearls for each surgery. Glaucoma surgeries included: 1- bleb surgery (namely trabeculectomy, with releasable sutures or with slip knots, deep sclerectomy, Ahmed valve, Baerveldt tube), 2- MIGS with bleb, also known as MIBS (including XEN 45, XEN 63, and Preserflo), 3- MIGS increasing supra-choroidal flow (iStar), 4-MIGS increasing trabecular flow (iStent, gonioscopy-assisted transluminal trabeculotomy - GATT, goniotomy, excimer laser trabeculostomy -ELT), and 5-MIGS decreasing aqueous humor production (endocyclophotocoagulation, ECP). There was also needling (ab interno and ab externo) performed at the operating room and irido-zonulo-hyaloïdectomy (IZHV). Each technique had different indications and contra-indications. Conclusion: MIGS are valuable in glaucoma surgery, such as traditional surgery with trabeculectomy and tubes. All glaucoma surgery can be combined with phacoemulsification (there may be a synergistic effect on MIGS + cataract surgery). In addition, some MIGS may be combined for further intraocular pressure lowering effect (for example, iStents with goniotomy and ECP). A good surgical technique and postoperative management are fundamental to increasing success and good practice in all glaucoma surgery. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title="glaucoma">glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=migs" title=" migs"> migs</a>, <a href="https://publications.waset.org/abstracts/search?q=surgery" title=" surgery"> surgery</a>, <a href="https://publications.waset.org/abstracts/search?q=video" title=" video"> video</a>, <a href="https://publications.waset.org/abstracts/search?q=review" title=" review"> review</a> </p> <a href="https://publications.waset.org/abstracts/162837/surgical-treatment-of-glaucoma-literature-and-video-review-of-blebs-tubes-and-micro-invasive-glaucoma-surgeries-migs" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/162837.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">83</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">42</span> Glaucoma with Normal IOP, Is It True Normal Tension glaucoma or Something Else!</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Sushma%20Tejwani">Sushma Tejwani</a>, <a href="https://publications.waset.org/abstracts/search?q=Shoruba%20Dinakaran"> Shoruba Dinakaran</a>, <a href="https://publications.waset.org/abstracts/search?q=Kushal%20Kacha"> Kushal Kacha</a>, <a href="https://publications.waset.org/abstracts/search?q=K.%20Bhujang%20Shetty"> K. Bhujang Shetty</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Introduction and aim: It is not unusual to find patients with glaucomatous damage and normal intraocular pressure, and to label a patient as Normal tension glaucoma (NTG) majority of clinicians depend on office Intraocular pressures (IOP) recordings; hence, the concern is that whether we are missing the late night or early morning spikes in this group of patients. Also, ischemia to the optic nerve is one of the presumed causes of damage in these patients, however demonstrating the same has been a challenge. The aim of this study was to evaluate IOP variations and patterns in a series of patients with open angles, glaucomatous discs or fields but normal office IOP, and in addition to identify ischemic factors for true NTG patients. Materials & Methods: This was an observational cross- sectional study from a tertiary care centre. The patients that underwent full day DVT from Jan 2012 to April 2014 were studied. All patients underwent IOP measurement on Goldmann applanation tonometry every 3 hours for 24 hours along with a recording of the blood pressure (BP). Further patients with normal IOP throughout the 24- hour period were evaluated with a cardiologist for echocardiography and carotid Doppler. Results: There were 47 patients and a maximum number of patients studied was in the age group of 50-70 years. A biphasic IOP peak was noted for almost all the patients. Out of the 47 patients, 2 were excluded from analysis as they were on treatment.20 patients (42%) were diagnosed on DVT to have an IOP spike and were then diagnosed as open angle glaucoma and another 25 (55%) were diagnosed to have normal tension glaucoma and were subsequently advised a carotid Doppler and a cardiologists consult. Another interesting finding was that 9 patients had a nocturnal dip in their BP and 3 were found to have carotid artery stenosis. Conclusion: A continuous 24-hour monitoring of the IOP and BP is a very useful albeit mildly cumbersome tool which provides a wealth of information in cases of glaucoma presenting with normal office pressures. It is of great value in differentiating between normal tension glaucoma patients & open angle glaucoma patients. It also helps in timely diagnosis & possible intervention due to referral to a cardiologist in cases of carotid artery stenosis. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=carotid%20artery%20disease%20in%20NTG" title="carotid artery disease in NTG">carotid artery disease in NTG</a>, <a href="https://publications.waset.org/abstracts/search?q=diurnal%20variation%20of%20IOP" title=" diurnal variation of IOP"> diurnal variation of IOP</a>, <a href="https://publications.waset.org/abstracts/search?q=ischemia%20in%20glaucoma" title=" ischemia in glaucoma"> ischemia in glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=normal%20tension%20glaucoma" title=" normal tension glaucoma"> normal tension glaucoma</a> </p> <a href="https://publications.waset.org/abstracts/29713/glaucoma-with-normal-iop-is-it-true-normal-tension-glaucoma-or-something-else" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/29713.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">285</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">41</span> Advanced Eales’ Disease with Neovascular Glaucoma at First Presentation: Case Report</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Mohammed%20A.%20Alfayyadh">Mohammed A. Alfayyadh</a>, <a href="https://publications.waset.org/abstracts/search?q=Halla%20A.%20AlAbdulhadi"> Halla A. AlAbdulhadi</a>, <a href="https://publications.waset.org/abstracts/search?q=Mahdi%20H.%20Almubarak"> Mahdi H. Almubarak</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Purpose: Eales’ disease is an idiopathic vasculitis that affects the peripheral retina. It is characterized by recurrent vitreous hemorrhage as a complication of retinal neovascularization. It is more prevalent in India and affects young males. Here we present a patient with neovascular glaucoma as a rare first presentation of Eales’ disease. Observations: This is a 24-year-old Indian gentleman, who complained of a sudden decrease in vision in the left eye over less than 24 hours, along with frontal headache and eye pain for the last three weeks. Ocular examination revealed peripheral retinal ischemia in the right eye, very high intraocular pressure, rubeosis iridis, vitreous hemorrhage and extensive retinal ischemia in the left eye, vascular sheathing and neovascularization in both eyes. Purified protein derivative skin test was positive. The patient was managed with anti-glaucoma, intravitreal anti-vascular endothelial growth factor and laser photocoagulation. Systemic steroids and anti-tuberculous therapy were also initiated. Conclusions: Neovascular glaucoma is an infrequent complication of Eales’ disease. However, the lack of early detection of the disease in the early stages might lead to such serious complication. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=case%20report" title="case report">case report</a>, <a href="https://publications.waset.org/abstracts/search?q=Eales%E2%80%99%20disease" title=" Eales’ disease"> Eales’ disease</a>, <a href="https://publications.waset.org/abstracts/search?q=mycobacterium%20tuberculosis" title=" mycobacterium tuberculosis"> mycobacterium tuberculosis</a>, <a href="https://publications.waset.org/abstracts/search?q=neovascular%20glaucoma" title=" neovascular glaucoma"> neovascular glaucoma</a> </p> <a href="https://publications.waset.org/abstracts/138169/advanced-eales-disease-with-neovascular-glaucoma-at-first-presentation-case-report" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/138169.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">127</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">40</span> Success of Trabeculectomy: May Not Always Depend on Mitomycin C</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Sushma%20Tejwani">Sushma Tejwani</a>, <a href="https://publications.waset.org/abstracts/search?q=Shoruba%20Dinakaran"> Shoruba Dinakaran</a>, <a href="https://publications.waset.org/abstracts/search?q=Rupa%20Rokhade"> Rupa Rokhade</a>, <a href="https://publications.waset.org/abstracts/search?q=K.%20Bhujang%20Shetty"> K. Bhujang Shetty </a> </p> <p class="card-text"><strong>Abstract:</strong></p> Introduction and aim: One of the major causes for failure of trabeculectomy is fibrosis and scarring of subconjunctival tissue around the bleb, and hence intra operative usage of anti-fibrotic agents like Mitomycin C (MMC) has become very popular. However, the long term effects of MMC like thin, avascular bleb, hypotony, bleb leaks and late onset endophthalmitis cannot be ignored, and may preclude its usage in routine trabeculectomy. In this particular study we aim to study the outcomes of trabeculectomy with and without MMC in uncomplicated glaucoma patients. Methods: Retrospective study of series of patients that underwent trabeculectomy with or without cataract surgery in glaucoma department of a tertiary eye care centre by a single surgeon for primary open angle glaucoma (POAG), angle closure glaucoma (PACG), Pseudoexfoliation glaucoma (PXF glaucoma). Patients with secondary glaucoma, juvenile and congenital glaucoma were excluded; also patients undergoing second trabeculectomy were excluded. The outcomes were studied in terms of IOP control at 1 month, 6 months, and 1 year and were analyzed separately for surgical outcomes with and without MMC. Success was considered if IOP was < 16 mmHg on applanation tonometry. Further, the necessity of medication, 5 fluorouracil (5FU) postoperative injections, needling post operatively was noted. Results: Eighty nine patient’s medical records were reviewed, of which 58 patients had undergone trabeculectomy without MMC and 31 with MMC. Mean age was 62.4 (95%CI 61- 64), 34 were females and 55 males. MMC group (n=31): Preoperative mean IOP was 21.1mmHg (95% CI: 17.6 -24.6), and 22 patients had IOP > 16. Three out of 33 patients were on single medication and rests were on multiple drugs. At 1 month (n=27) mean IOP was 12.4 mmHg (CI: 10.7-14), and 31/33 had success. At 6 months (n=18) mean IOP was 13mmHg (CI: 10.3-14.6) and 16/18 had good outcome, however at 1 year only 11 patients were available for follow up and 91% (10/11) had success. Overall, 3 patients required medication and one patient required postoperative injection of 5 FU. No MMC group (n=58): Preoperative mean IOP was 21.9 mmHg (CI: 19.8-24.2), and 42 had IOP > 16 mmHg. 12 out of 58 patients were on single medication and rests were on multiple drugs. At 1 month (n=52) mean IOP was14.6mmHg (CI: 13.2-15.9), and 45/ 58 had IOP < 16mmHg. At 6 months (n=31) mean IOP was 13.5 mmHg (CI: 11.9-15.2) and 26/31 had success, however at 1 year only 23 patients came for follow up and of these 87% (20/23) patients had success. Overall, 1 patient required needling, 5 required 5 FU injections and 5 patients required medication. The success rates at each follow up visit were not significantly different in both the groups. Conclusion: Intra-operative MMC usage may not be required in all patients undergoing trabeculectomy, and the ones without MMC also have fairly good outcomes in primary glaucoma. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma%20filtration%20surgery" title="glaucoma filtration surgery">glaucoma filtration surgery</a>, <a href="https://publications.waset.org/abstracts/search?q=mitomycin%20C" title=" mitomycin C"> mitomycin C</a>, <a href="https://publications.waset.org/abstracts/search?q=outcomes%20of%20trabeculectomy" title=" outcomes of trabeculectomy"> outcomes of trabeculectomy</a>, <a href="https://publications.waset.org/abstracts/search?q=wound%20modulation" title=" wound modulation"> wound modulation</a> </p> <a href="https://publications.waset.org/abstracts/29709/success-of-trabeculectomy-may-not-always-depend-on-mitomycin-c" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/29709.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">274</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">39</span> Efficacy of Collagen Matrix Implants in Phacotrabeculectomy with Mitomycin C at One Year</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Lalit%20Tejwani">Lalit Tejwani</a>, <a href="https://publications.waset.org/abstracts/search?q=Reetika%20Sharma"> Reetika Sharma</a>, <a href="https://publications.waset.org/abstracts/search?q=Arun%20Singhvi"> Arun Singhvi</a>, <a href="https://publications.waset.org/abstracts/search?q=Himanshu%20Shekhar"> Himanshu Shekhar</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Purpose: To assess the efficacy of collagen matrix implant (Ologen) in phacotrabeculectomy augmented with mitomycin C (MMC). Methods: A biodegradable collagen matrix (Ologen) was placed in the subconjunctival and subscleral space in twenty-two eyes of 22 patients with glaucoma and cataract who underwent combined phacoemulsification and trabeculectomy augmented with MMC. All of them were examined preoperatively and on the first postoperative day. They were followed for twelve months after surgery. Any intervention needed in follow-up period was noted. Any complication was recorded. The primary outcome measure was postoperative intraocular pressure at one year follow-up. Any additional postoperative treatments needed and adverse events were noted. Results: The mean age of patients included in the study was 57.77 ± 9.68 years (range=36 to 70 years). All the patients were followed for at least one year. Three patients had history of failed trabeculectomy. Fifteen patients had chronic angle closure glaucoma with cataract, five had primary open angle glaucoma with cataract, one had uveitic glaucoma with cataract, and one had juvenile open angle glaucoma with cataract. Mean preoperative IOP was 32.63 ± 8.29 mm Hg, eighteen patients were on oral antiglaucoma medicines. The mean postoperative IOP was 10.09 ± 2.65 mm Hg at three months, 10.36 ± 2.19 mm Hg at six months and 11.36 ± 2.72 mm Hg at one year follow up. No adverse effect related to Ologen was seen. Anterior chamber reformation was done in five patients, and three needed needling of bleb. Four patients needed additional antiglaucoma medications in the follow-up period. Conclusions: Combined phacotrabeculectomy with MMC with Ologen implantation appears to be a safe and effective option in glaucoma patients needing trabeculectomy with significant cataract. Comparative studies with longer duration of follow-up in larger number of patients are needed. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=combined%20surgery" title="combined surgery">combined surgery</a>, <a href="https://publications.waset.org/abstracts/search?q=ologen" title=" ologen"> ologen</a>, <a href="https://publications.waset.org/abstracts/search?q=phacotrabeculectomy" title=" phacotrabeculectomy"> phacotrabeculectomy</a>, <a href="https://publications.waset.org/abstracts/search?q=success" title=" success"> success</a> </p> <a href="https://publications.waset.org/abstracts/75958/efficacy-of-collagen-matrix-implants-in-phacotrabeculectomy-with-mitomycin-c-at-one-year" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/75958.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">213</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">38</span> Role of Ologen in Previously Failed Trabeculectomy in Advanced Glaucoma</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Reetika%20Sharma">Reetika Sharma</a>, <a href="https://publications.waset.org/abstracts/search?q=Lalit%20Tejwani"> Lalit Tejwani</a>, <a href="https://publications.waset.org/abstracts/search?q=Himanshu%20Shekhar"> Himanshu Shekhar</a>, <a href="https://publications.waset.org/abstracts/search?q=Arun%20Singhvi"> Arun Singhvi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Purpose: Advanced Glaucoma with Failed trab is not an uncommon sight in glaucoma clinic, and such cases usually tend to present with high intraocular pressure (IOP) and advanced cupping, or even glaucomatous atrophy stage. Re-surgery is needed for such cases, and wound modulation poses a major challenge in these cases. We share our experience in this case series with the use of Ologen (collagen matrix implant) along with MMC 0.04% used in surgery. The purpose of the study was to evaluate the efficacy and outcome of collagen matrix implant in re-trabeculectomy in advanced glaucoma cases. Methodology: Eleven eyes of 11 patients (one eye of one patient) underwent re-trabeculectomy surgery with MMC and Ologen. Ologen implant was used in sub scleral and subconjunctival space, as a spacer and wound modulator. In five cases, triple modulation with implant soaked in anti-VEGF was used. Results: All patients had cupping more than 0.9, and one case was GOA. All cases were on maximal medication at presentation and majority were on systemic anti-glaucoma therapy also. Post-surgery, follow-up ranged from 13 – 34 months, and all cases had a follow longer than the gap between previous surgery (which was failed) and re-trab. One case needed AC reformation and one needling was done. Phaco was done at same sitting in four cases. All cases had their IOP lowered post surgery, and vision was maintained in all, however one case was considered as failed re-surgery case. Topical medication was needed in seven cases post-surgery also. Conclusion: Ologen as adjuvant should be considered in all re-trab cases and all high risk and advanced cases, and triple modulation can be next step in these cases. Aggressive IOP control and non- reluctance to continue topical medications post second surgery should be considered in such cases, to give them best possible vision. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=failed%20trabeculectomy" title="failed trabeculectomy">failed trabeculectomy</a>, <a href="https://publications.waset.org/abstracts/search?q=ologen" title=" ologen"> ologen</a>, <a href="https://publications.waset.org/abstracts/search?q=trabeculectomy" title=" trabeculectomy"> trabeculectomy</a>, <a href="https://publications.waset.org/abstracts/search?q=advanced%20glaucoma" title=" advanced glaucoma"> advanced glaucoma</a> </p> <a href="https://publications.waset.org/abstracts/75961/role-of-ologen-in-previously-failed-trabeculectomy-in-advanced-glaucoma" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/75961.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">334</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">37</span> Neuroprotection against N-Methyl-D-Aspartate-Induced Optic Nerve and Retinal Degeneration Changes by Philanthotoxin-343 to Alleviate Visual Impairments Involve Reduced Nitrosative Stress</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Izuddin%20Fahmy%20Abu">Izuddin Fahmy Abu</a>, <a href="https://publications.waset.org/abstracts/search?q=Mohamad%20Haiqal%20Nizar%20Mohamad"> Mohamad Haiqal Nizar Mohamad</a>, <a href="https://publications.waset.org/abstracts/search?q=Muhammad%20Fattah%20Fazel"> Muhammad Fattah Fazel</a>, <a href="https://publications.waset.org/abstracts/search?q=Renu%20Agarwal"> Renu Agarwal</a>, <a href="https://publications.waset.org/abstracts/search?q=Igor%20Iezhitsa"> Igor Iezhitsa</a>, <a href="https://publications.waset.org/abstracts/search?q=Nor%20Salmah%20Bakar"> Nor Salmah Bakar</a>, <a href="https://publications.waset.org/abstracts/search?q=Henrik%20%20Franzyk"> Henrik Franzyk</a>, <a href="https://publications.waset.org/abstracts/search?q=Ian%20Mellor"> Ian Mellor</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma is the global leading cause of irreversible blindness. Currently, the available treatment strategy only involves lowering intraocular pressure (IOP); however, the condition often progresses despite lowered or normal IOP in some patients. N-methyl-D-aspartate receptor (NMDAR) excitotoxicity often occurs in neurodegeneration-related glaucoma; thus it is a relevant target to develop a therapy based on neuroprotection approach. This study investigated the effects of Philanthotoxin-343 (PhTX-343), an NMDAR antagonist, on the neuroprotection of NMDA-induced glaucoma to alleviate visual impairments. Male Sprague-Dawley rats were equally divided: Groups 1 (control) and 2 (glaucoma) were intravitreally injected with phosphate buffer saline (PBS) and NMDA (160nM), respectively, while group 3 was pre-treated with PhTX-343 (160nM) 24 hours prior to NMDA injection. Seven days post-treatments, rats were subjected to visual behavior assessments and subsequently euthanized to harvest their retina and optic nerve tissues for histological analysis and determination of nitrosative stress level using 3-nitrotyrosine ELISA. Visual behavior assessments via open field, object, and color recognition tests demonstrated poor visual performance in glaucoma rats indicated by high exploratory behavior. PhTX-343 pre-treatment appeared to preserve visual abilities as all test results were significantly improved (p < 0.05). H&E staining of the retina showed a marked reduction of ganglion cell layer thickness in the glaucoma group; in contrast, PhTX-343 significantly increased the number by 1.28-folds (p < 0.05). PhTX-343 also increased the number of cell nuclei/100μm2 within inner retina by 1.82-folds compared to the glaucoma group (p < 0.05). Toluidine blue staining of optic nerve tissues showed that PhTX-343 reduced the degeneration changes compared to the glaucoma group which exhibited vacuolation overall sections. PhTX-343 also decreased retinal 3- nitrotyrosine concentration by 1.74-folds compared to the glaucoma group (p < 0.05). All results in PhTX-343 group were comparable to control (p > 0.05). We conclude that PhTX-343 protects against NMDA-induced changes and visual impairments in the rat model by reducing nitrosative stress levels. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=excitotoxicity" title="excitotoxicity">excitotoxicity</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=nitrosative%20stress" title=" nitrosative stress "> nitrosative stress </a>, <a href="https://publications.waset.org/abstracts/search?q=NMDA%20receptor" title=" NMDA receptor "> NMDA receptor </a>, <a href="https://publications.waset.org/abstracts/search?q=N-methyl-D-aspartate" title=" N-methyl-D-aspartate "> N-methyl-D-aspartate </a>, <a href="https://publications.waset.org/abstracts/search?q=philanthotoxin" title=" philanthotoxin"> philanthotoxin</a>, <a href="https://publications.waset.org/abstracts/search?q=visual%20behaviour" title=" visual behaviour"> visual behaviour</a> </p> <a href="https://publications.waset.org/abstracts/120388/neuroprotection-against-n-methyl-d-aspartate-induced-optic-nerve-and-retinal-degeneration-changes-by-philanthotoxin-343-to-alleviate-visual-impairments-involve-reduced-nitrosative-stress" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/120388.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">137</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">36</span> A Sub-Conjunctiva Injection of Rosiglitazone for Anti-Fibrosis Treatment after Glaucoma Filtration Surgery</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Yang%20Zhao">Yang Zhao</a>, <a href="https://publications.waset.org/abstracts/search?q=Feng%20Zhang"> Feng Zhang</a>, <a href="https://publications.waset.org/abstracts/search?q=Xuanchu%20Duan"> Xuanchu Duan</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Trans-differentiation of human Tenon fibroblasts (HTFs) to myo-fibroblasts and fibrosis of episcleral tissue are the most common reasons for the failure of glaucoma filtration surgery, with limited treatment options like antimetabolites which always have side-effects such as leakage of filter bulb, infection, hypotony, and endophthalmitis. Rosiglitazone, a specific thiazolidinedione is a synthetic high-affinity ligand for PPAR-r, which has been used in the treatment of type2 diabetes, and found to have pleiotropic functions against inflammatory response, cell proliferation and tissue fibrosis and to benefit to a variety of diseases in animal myocardium models, steatohepatitis models, etc. Here, in vitro we cultured primary HTFs and stimulated with TGF- β to induced myofibrogenic, then treated cells with Rosiglitazone to assess for fibrogenic response. In vivo, we used rabbit glaucoma model to establish the formation of post- trabeculectomy scarring. Then we administered subconjunctival injection with Rosiglitazone beside the ﬁltering bleb, later protein, mRNA and immunofluorescence of fibrogenic markers are checked, and filtering bleb condition was measured. In vitro, we found Rosiglitazone could suppressed proliferation and migration of fibroblasts through macroautophagy via TGF- β /Smad signaling pathway. In vivo, on postoperative day 28, the mean number of ﬁbroblasts in Rosiglitazone injection group was signiﬁcantly the lowest and had the least collagen content and connective tissue growth factor. Rosiglitazone effectively controlled human and rabbit fibroblasts in vivo and in vitro. Its subconjunctiiva application may represent an effective, new avenue for the prevention of scarring after glaucoma surgery. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=fibrosis" title="fibrosis">fibrosis</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=macroautophagy" title=" macroautophagy"> macroautophagy</a>, <a href="https://publications.waset.org/abstracts/search?q=rosiglitazone" title=" rosiglitazone"> rosiglitazone</a> </p> <a href="https://publications.waset.org/abstracts/73539/a-sub-conjunctiva-injection-of-rosiglitazone-for-anti-fibrosis-treatment-after-glaucoma-filtration-surgery" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/73539.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">274</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">35</span> Theoretical Study of Carbonic Anhydrase-Ii Inhibitors for Treatment of Glaucoma</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=F.%20Boukli%20Hacene">F. Boukli Hacene</a>, <a href="https://publications.waset.org/abstracts/search?q=W.%20Soufi"> W. Soufi</a>, <a href="https://publications.waset.org/abstracts/search?q=S.%20Ghalem"> S. Ghalem</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Glaucoma disease is a progressive degenerative optic neuropathy, with irreversible visual field deficits and high eye pressure being one of the risk factors. Sulfonamides are carbonic anhydrase-II inhibitors that aim to decrease the secretion of aqueous humor by direct inhibition of this enzyme at the level of the ciliary processes. These drugs present undesirable effects that are difficult to accept by the patient. In our study, we are interested in the inhibition of carbonic anhydrase-II by different natural ligands (curcumin analogues) using molecular modeling methods using molecular operating environment (MOE) software to predict their interaction with this enzyme. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=carbonic%20anhydrase-II" title="carbonic anhydrase-II">carbonic anhydrase-II</a>, <a href="https://publications.waset.org/abstracts/search?q=curcumin%20analogues" title=" curcumin analogues"> curcumin analogues</a>, <a href="https://publications.waset.org/abstracts/search?q=drug%20research" title=" drug research"> drug research</a>, <a href="https://publications.waset.org/abstracts/search?q=molecular%20modeling" title=" molecular modeling"> molecular modeling</a> </p> <a href="https://publications.waset.org/abstracts/156555/theoretical-study-of-carbonic-anhydrase-ii-inhibitors-for-treatment-of-glaucoma" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/156555.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">89</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">34</span> Design and Simulation High Sensitive MEMS Capacitive Pressure Sensor with Small Size for Glaucoma Treatment</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Yadollah%20Hezarjaribi">Yadollah Hezarjaribi</a>, <a href="https://publications.waset.org/abstracts/search?q=Mahdie%20Yari%20Esboi"> Mahdie Yari Esboi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> In this paper, a novel MEMS capacitive pressure sensor with small size and high sensitivity is presented. This sensor has the separated clamped square diaphragm and the movable plate. The diaphragm material is polysilicon. The movable and fixed plates and mechanical coupling are gold. The substrate and diaphragm are pyrex glass and polysilicon, respectively. In capacitive sensor the sensitivity is proportional to deflection and capacitance changes with pressure for this reason with this design is improved the capacitance and sensitivity with small size. This sensor is designed for low pressure between 0-60 mmHg that is used for medical application such as treatment of an incurable disease called glaucoma. The size of this sensor is 350×350 µm2 and the thickness of the diaphragm is 2µm with 1μ air gap. This structure is designed by intellisuite software. In this MEMS capacitive pressure sensor the sensor sensitivity, diaphragm mechanical sensitivity for polysilicon diaphragm are 0.0469Pf/mmHg, 0.011 μm/mmHg, respectively. According to the simulating results for low pressure, the structure with polysilicon diaphragm has more change of the displacement and capacitance, this leads to high sensitivity than other diaphragms. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title="glaucoma">glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=MEMS%20capacitive%20pressure%20sensor" title=" MEMS capacitive pressure sensor"> MEMS capacitive pressure sensor</a>, <a href="https://publications.waset.org/abstracts/search?q=square%20clamped%20diaphragm" title=" square clamped diaphragm"> square clamped diaphragm</a>, <a href="https://publications.waset.org/abstracts/search?q=polysilicon" title=" polysilicon"> polysilicon</a> </p> <a href="https://publications.waset.org/abstracts/46427/design-and-simulation-high-sensitive-mems-capacitive-pressure-sensor-with-small-size-for-glaucoma-treatment" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/46427.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">319</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">33</span> Bilateral Simultaneous Acute Primary Angle Closure Glaucoma: A Remarkable Case</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Nita%20Nurlaila%20Kadarwaty">Nita Nurlaila Kadarwaty</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Purpose: This study presents a rare case of bilateral Acute Primary Angle Closure Glaucoma (PACG). Method: A case report of a 64-year-old woman with a good outcome Acute PACG in both eyes who underwent phacotrabeculectomy surgery. Result: A 64-year-old woman complained of acute pain in both eyes, accompanied by decreased vision, photophobia, and seeing halos for three weeks. There was no history of trauma, steroid or other systemic drugs used, or intraocular surgery before. Ophthalmologic examination revealed a right eye (RE) visual acuity of 0.1, left eye (LE) 0.2. RE intraocular pressure (IOP) was 12 mmhg and LE: 36.4 mmHg in medication of timolol maleat ED and acetazolamide oral. Both eyes' anterior segments revealed mixed injection, corneal edema, shallow anterior chamber, posterior synechiae, mid-dilatation pupil with negative pupillary reflection, and cloudy lens without intumescent. There was a glaucomatous optic and closed iridocorneal angle on the gonioscopy. Initial treatments included oral acetazolamide and potassium aspartate 250 mg three times a day, timolol maleate ED 0.5% twice a day, and prednisolone acetate ED 1% four times a day. This patient underwent trabeculectomy, phacoemulsification, and implantation of IOL in both eyes. One week after the surgeries, both eyes showed decreased IOP and good visual improvement. Conclusion: Bilateral simultaneous Acute PACG is generally severe and results in a poor outcome. It causes rapidly progressive visual loss and is often irreversible. Phacotrabeculectomy has more benefits compared to only phacoemulsification for the intervention regarding the reduced IOP post-surgical. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=acute%20primary%20angle%20closure%20glaucoma" title="acute primary angle closure glaucoma">acute primary angle closure glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=intraocular%20pressure" title=" intraocular pressure"> intraocular pressure</a>, <a href="https://publications.waset.org/abstracts/search?q=phacotrabeculectomy" title=" phacotrabeculectomy"> phacotrabeculectomy</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a> </p> <a href="https://publications.waset.org/abstracts/172153/bilateral-simultaneous-acute-primary-angle-closure-glaucoma-a-remarkable-case" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/172153.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">73</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">32</span> Comparison of Visual Field Tests in Glaucoma Patients with a Central Visual Field Defect</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Hye-Young%20Shin">Hye-Young Shin</a>, <a href="https://publications.waset.org/abstracts/search?q=Hae-Young%20Lopilly%20Park"> Hae-Young Lopilly Park</a>, <a href="https://publications.waset.org/abstracts/search?q=Chan%20Kee%20Park"> Chan Kee Park</a> </p> <p class="card-text"><strong>Abstract:</strong></p> We compared the 24-2 and 10-2 visual fields (VFs) and investigate the degree of discrepancy between the two tests in glaucomatous eyes with central VF defects. In all, 99 eyes of 99 glaucoma patients who underwent both the 24-2 VF and 10-2 VF tests within 6 months were enrolled retrospectively. Glaucomatous eyes involving a central VF defect were divided into three groups based on the average total deviation (TD) of 12 central points in the 24-2 VF test (N = 33, in each group): group 1 (tercile with the highest TD), group 2 (intermediate TD), and group 3 (lowest TD). The TD difference was calculated by subtracting the average TD of the 10-2 VF test from the average TD of 12 central points in the 24-2 VF test. The absolute central TD difference in each quadrant was defined as the absolute value of the TD value obtained by subtracting the average TD of four central points in the 10-2 VF test from the innermost TD in the 24-2 VF test in each quadrant. The TD differences differed significantly between group 3 and groups 1 and 2 (P < 0.001). In the superonasal quadrant, the absolute central TD difference was significantly greater in group 2 than in group 1 (P < 0.05). In the superotemporal quadrant, the absolute central TD difference was significantly greater in group 3 than in groups 1 and 2 (P < 0.001). Our results indicate that the results of VF tests for different VFs can be inconsistent, depending on the degree of central defects and the VF quadrant. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=central%20visual%20field%20defect" title="central visual field defect">central visual field defect</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=10-2%20visual%20field" title=" 10-2 visual field"> 10-2 visual field</a>, <a href="https://publications.waset.org/abstracts/search?q=24-2%20visual%20field" title=" 24-2 visual field"> 24-2 visual field</a> </p> <a href="https://publications.waset.org/abstracts/97801/comparison-of-visual-field-tests-in-glaucoma-patients-with-a-central-visual-field-defect" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/97801.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">176</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">31</span> Clinical and Molecular Characterization of 120 Families with Sporadic Juvenile Onset Open Angle Glaucoma</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Bindu%20I.%20Somarajan">Bindu I. Somarajan</a>, <a href="https://publications.waset.org/abstracts/search?q=Viney%20Gupta"> Viney Gupta</a>, <a href="https://publications.waset.org/abstracts/search?q=Gagandeep%20%20Kaur%20Walia"> Gagandeep Kaur Walia</a>, <a href="https://publications.waset.org/abstracts/search?q=Jasbir%20Kaur"> Jasbir Kaur</a>, <a href="https://publications.waset.org/abstracts/search?q=Sunil%20Kumar"> Sunil Kumar</a>, <a href="https://publications.waset.org/abstracts/search?q=Shikha%20Gupta"> Shikha Gupta</a>, <a href="https://publications.waset.org/abstracts/search?q=Abadh%20K.%20Chaurasia"> Abadh K. Chaurasia</a>, <a href="https://publications.waset.org/abstracts/search?q=Dinesh%20Gupa"> Dinesh Gupa</a>, <a href="https://publications.waset.org/abstracts/search?q=Abhinav%20Kaushik"> Abhinav Kaushik</a>, <a href="https://publications.waset.org/abstracts/search?q=Aditi%20Mehta"> Aditi Mehta</a>, <a href="https://publications.waset.org/abstracts/search?q=Vipin%20Gupta"> Vipin Gupta</a>, <a href="https://publications.waset.org/abstracts/search?q=Arundhati%20Sharma"> Arundhati Sharma</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: Juvenile onset primary open angle glaucoma (JOAG), affects individuals under the age of 40 years. Studies on a few families of JOAG, that led to the discovery of the Myocilin gene, reported the disease to have an autosomal dominant pattern of inheritance. However, sporadic forms of JOAG been seen to be more common in some populations. Most pathological homozygous mutations in the CYP1B1 gene associated with JOAG have been seen among sporadic cases. Given the higher prevalence of sporadic JOAG cases in our population, we aimed to look for common mutations E229K and R368H, the two most common variants in the CYP1B1 gene associated with glaucoma. Objective: To determine the frequency and evaluate genotype phenotype correlation of CYP1B1 E229K and R368H mutations in a cohort of 120 sporadic Juvenile open angle glaucoma patients.Methods: Unrelated JOAG patients whose first degree relatives had been examined and found to be unaffected were included in the study. The patients and their parents were screened for E229K and R368H mutations. The phenotypic characteristics were compared between probands with and with out these mutations by SPSS v16. Results: Out of 120 JOAG patients included in the study, the E229K mutation was seen in 9 probands (7.5%) and R368H in 7 (5.8%). The average age of onset of the disease (p=0.3) and the highest untreated IOP (p=0.4) among those carrying mutations was not significantly different from those who did not have these mutations. The proportion of probands with angle dysgenesis among those with E229K and R368H mutations was 70% (11 out of 16) in comparison to 65% (67 out of 104) of those who did not harbour these mutations (p=0.56). Similarly the probands with moderate to high myopia among those with E229K and R368H mutations was 20% (3 out of 16) in comparison to 18% (18 out of 104) of those who did not harbour these mutations(p=0.59). Conclusion: The frequency of E229K and R368H mutations of the CYP1B1 gene is low even among sporadic JOAG patients. Moreover there is no clinical correlation between the presence of these mutations and disease severity <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=CYP1B1" title="CYP1B1">CYP1B1</a>, <a href="https://publications.waset.org/abstracts/search?q=gene" title=" gene"> gene</a>, <a href="https://publications.waset.org/abstracts/search?q=IOP" title=" IOP"> IOP</a>, <a href="https://publications.waset.org/abstracts/search?q=JOAG" title=" JOAG"> JOAG</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation" title=" mutation"> mutation</a> </p> <a href="https://publications.waset.org/abstracts/77908/clinical-and-molecular-characterization-of-120-families-with-sporadic-juvenile-onset-open-angle-glaucoma" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/77908.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">333</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">30</span> The Retinoprotective Effects and Mechanisms of Fungal Ingredient 3,4-Dihydroxybenzalacetone through Inhibition of Retinal Müller and Microglial Activation</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Yu-Wen%20Cheng">Yu-Wen Cheng</a>, <a href="https://publications.waset.org/abstracts/search?q=Jau-Der%20Ho"> Jau-Der Ho</a>, <a href="https://publications.waset.org/abstracts/search?q=Liang-Huan%20Wu"> Liang-Huan Wu</a>, <a href="https://publications.waset.org/abstracts/search?q=Fan-Li%20Lin"> Fan-Li Lin</a>, <a href="https://publications.waset.org/abstracts/search?q=Li-Huei%20Chen"> Li-Huei Chen</a>, <a href="https://publications.waset.org/abstracts/search?q=Hung-Ming%20Chang"> Hung-Ming Chang</a>, <a href="https://publications.waset.org/abstracts/search?q=Yueh-Hsiung%20Kuo"> Yueh-Hsiung Kuo</a>, <a href="https://publications.waset.org/abstracts/search?q=George%20Hsiao"> George Hsiao</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Retina glial activation and neuroinflammation have been confirmed to cause devastating responses in retinodegenerative diseases. The expression and activation of matrix metalloproteinase (MMP)-9 and inducible nitric oxide synthase (iNOS) could be exerted as the crucial pathological factors in glaucoma- and blue light-induced retinal injuries. The present study aimed to investigate the retinoprotective effects and mechanisms of fungal ingredient 3,4-dihydroxybenzalacetone (DBL) isolated from Phellinus linteus in the retinal glial activation and retinodegenerative animal models. According to the cellular studies, DBL significantly and concentration-dependently abrogated MMP-9 activation and expression in TNFα-stimulated retinal Müller (rMC-1) cells. We found the inhibitory activities of DBL were strongly through the STAT- and ERK-dependent pathways. Furthermore, DBL dramatically attenuated MMP-9 activation in the stimulated Müller cells exposed to conditioned media from LPS-stimulated microglia BV-2 cells. On the other hand, DBL strongly suppressed LPS-induced production of NO and ROS and expression of iNOS in microglia BV-2 cells. Consistently, the phosphorylation of STAT was substantially blocked by DBL in LPS-stimulated microglia BV-2 cells. In the evaluation of retinoprotective functions, the high IOP-induced scotopic electroretinographic (ERG) deficit and blue light-induced abnormal pupillary light response (PLR) were assessed. The deficit scotopic ERG responses markedly recovered by DBL in a rat model of glaucoma-like ischemia/reperfusion (I/R)-injury. DBL also reduced the aqueous gelatinolytic activity and retinal MMP-9 expression in high IOP-injured conditions. Additionally, DBL could restore the abnormal PLR and reduce retinal MMP-9 activation. In summary, DBL could ameliorate retinal neuroinflammation and MMP-9 activation by predominantly inhibiting STAT3 activation in the retinal Müller cells and microglia, which exhibits therapeutic potential for glaucoma and other retinal degenerative diseases. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title="glaucoma">glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=blue%20light" title=" blue light"> blue light</a>, <a href="https://publications.waset.org/abstracts/search?q=DBL" title=" DBL"> DBL</a>, <a href="https://publications.waset.org/abstracts/search?q=retinal%20M%C3%BCller%20cell" title=" retinal Müller cell"> retinal Müller cell</a>, <a href="https://publications.waset.org/abstracts/search?q=MMP-9" title=" MMP-9"> MMP-9</a>, <a href="https://publications.waset.org/abstracts/search?q=STAT" title=" STAT"> STAT</a>, <a href="https://publications.waset.org/abstracts/search?q=Microglia" title=" Microglia"> Microglia</a>, <a href="https://publications.waset.org/abstracts/search?q=iNOS" title=" iNOS"> iNOS</a>, <a href="https://publications.waset.org/abstracts/search?q=ERG" title=" ERG"> ERG</a>, <a href="https://publications.waset.org/abstracts/search?q=PLR" title=" PLR"> PLR</a> </p> <a href="https://publications.waset.org/abstracts/136717/the-retinoprotective-effects-and-mechanisms-of-fungal-ingredient-34-dihydroxybenzalacetone-through-inhibition-of-retinal-muller-and-microglial-activation" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/136717.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">139</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">29</span> Common Causes of Eye Removal Surgery in Turkish Patients: A Review of 226 Cases</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Titap%20Yazicioglu">Titap Yazicioglu</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Purpose: To determine the etiological factors responsible for the eye removal surgery and to evaluate our surgical results. Material and Methods: Medical records of 226 patients, who underwent eye removal surgery, were analyzed retrospectively. Demographic information, clinical history, surgical procedure, and histopathological data were all collected. Evisceration surgery was performed under general anesthesia in all patients except tumor cases and one patient with rhino-orbital mucormycosis. The patients were followed for an average of 16.46±10.78 months and checked for the possible complications, cosmesis, and functional results.Results: 144 men, and 82 women,with a mean age of 41.78±22.6 years, were underwent enucleation (n=15) or evisceration (n=211) due to traumatic (n=169) and non-traumatic (n=57) causes. In the traumatic group, 79.8% of 169 patients were injured by penetrating and 14.2% by blunt trauma.3.6% of the patients were injured in a traffic accident, and 2.4% of them were injured by explosives. In the non-traumatic group, 40% of 25 patients had post-traumatic endophthalmitis, 32% had endophthalmitis due to corneal ulceration and melting, and 24% had endophthalmitis after cataract surgery. One patient had panophthalmitis due to rhino-orbital mucormycosis. Another cause in the non-traumatic group was glaucoma, of which 92.3% had neovascular glaucoma, and 8.7% had congenital glaucoma. Of the 14 patients who were enucleated for tumor, 35.7% had retinoblastoma, 14.3% had medulloepithelioma, 42.9% had uveal melanoma, and 7.1% had metastatic tumor from paranasal sinuses.The most common complaint in the follow-up period was discharging, seen in all prosthesis-wearing patients. 13.3% of the patients had itching due to ocular prosthesis. 4.4% of the patients were complaining about deep superior sulcus. 4.4% had pyogenic granuloma, and 17.8% had implant exposure. Conclusion: Etiological factors should be carefully evaluated, and precautions should be taken in order to reduce the devastating effect of the physical loss of the eye. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=enucleation" title="enucleation">enucleation</a>, <a href="https://publications.waset.org/abstracts/search?q=evisceration" title=" evisceration"> evisceration</a>, <a href="https://publications.waset.org/abstracts/search?q=ocular%20injury" title=" ocular injury"> ocular injury</a>, <a href="https://publications.waset.org/abstracts/search?q=etiology" title=" etiology"> etiology</a>, <a href="https://publications.waset.org/abstracts/search?q=frequency" title=" frequency"> frequency</a> </p> <a href="https://publications.waset.org/abstracts/152395/common-causes-of-eye-removal-surgery-in-turkish-patients-a-review-of-226-cases" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/152395.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">111</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">28</span> Visual Improvement Outcome of Pars Plana Vitrectomy Combined Endofragmentation and Secondary IOL Implantation for Dropped Nucleus After Cataract Surgery : A Case Report</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Saut%20Samuel%20Simamora">Saut Samuel Simamora</a> </p> <p class="card-text"><strong>Abstract:</strong></p> PURPOSE: Nucleus drop is one of the most feared and severe complications of modern cataract surgery. The lens material may drop through iatrogenic breaks of the posterior capsule. The incidence of the nucleus as the complication of phacoemulsification increases concomitant to the increased frequency of phacoemulsification. Pars plana vitrectomy (PPV) followed by endofragmentation and secondary intraocular lens (IOL) implantation is the choice of management procedure. This case report aims to present the outcome of PPV for the treatment dropped nucleus after cataract surgery METHODS: A 65 year old female patient came to Vitreoretina department with chief complaints blurry vision in her left eye after phacoemulsification one month before. Ophthalmological examination revealed visual acuity of the right eye (VA RE) was 6/15, and the left eye (VA LE) was hand movement. The intraocular pressure (IOP) on the right eye was 18 mmHg, and on the left eye was 59 mmHg. On her left eye, there were aphakic, dropped lens nucleus and secondary glaucoma.RESULTS: The patient got antiglaucoma agent until her IOP was decreased. She underwent pars plana vitrectomy to remove dropped nucleus and iris fixated IOL. One week post operative evaluation revealed VA LE was 6/7.5 and iris fixated IOL in proper position. CONCLUSIONS: Nucleus drop generally occurs in phacoemulsification cataract surgery techniques. Retained lens nucleus or fragments in the vitreous may cause severe intraocular inflammation leading to secondary glaucoma. The proper and good management for retained lens fragments in nucleus drop give excellent outcome to patient. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=secondary%20glaucoma" title="secondary glaucoma">secondary glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=complication%20of%20phacoemulsification" title=" complication of phacoemulsification"> complication of phacoemulsification</a>, <a href="https://publications.waset.org/abstracts/search?q=nucleus%20drop" title=" nucleus drop"> nucleus drop</a>, <a href="https://publications.waset.org/abstracts/search?q=pars%20plana%20vitrectomy" title=" pars plana vitrectomy"> pars plana vitrectomy</a> </p> <a href="https://publications.waset.org/abstracts/171914/visual-improvement-outcome-of-pars-plana-vitrectomy-combined-endofragmentation-and-secondary-iol-implantation-for-dropped-nucleus-after-cataract-surgery-a-case-report" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/171914.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">79</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">27</span> Efficacy of In-Situ Surgical vs. Needle Revision on Late Failed Trabeculectomy Blebs</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Xie%20Xiaobin">Xie Xiaobin</a>, <a href="https://publications.waset.org/abstracts/search?q=Zhang%20Yan"> Zhang Yan</a>, <a href="https://publications.waset.org/abstracts/search?q=Shi%20Yipeng"> Shi Yipeng</a>, <a href="https://publications.waset.org/abstracts/search?q=Sun%20Wenying"> Sun Wenying</a>, <a href="https://publications.waset.org/abstracts/search?q=Chen%20Shuang"> Chen Shuang</a>, <a href="https://publications.waset.org/abstracts/search?q=Cai%20Zhipeng"> Cai Zhipeng</a>, <a href="https://publications.waset.org/abstracts/search?q=Zhang%20Hong"> Zhang Hong</a>, <a href="https://publications.waset.org/abstracts/search?q=Zhang%20Lixia"> Zhang Lixia</a>, <a href="https://publications.waset.org/abstracts/search?q=Xie%20Like"> Xie Like</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Objective: The objective of this research is to compare the efficacy of the late in-situ surgical revision augmented with continuous infusion and needle revision on failed trabeculectomy blebs. Methods From December 2018 to December 2021, a prospective randomized controlled trial was performed on 44 glaucoma patients with failed bleb ≥ 6months with medically uncontrolled in Eye Hospital, China Academy of Chinese Medical Sciences. They were randomly divided into two groups. 22 eyes of 22 patients underwent the late in-situ surgical revision with continuous anterior chamber infusion in the study group, and 22 of 22 patients were treated with needle revision in the control group. Main outcome measures include preoperative and postoperative intraocular pressure (IOP), the number of anti-glaucoma medicines, the operation success rate, and the postoperative complications. Results The postoperative IOP values decreased significantly from the baseline in both groups (both P<0.05). IOP was significantly lower in the study group than in the control group at one week, 1, and 3 months postoperatively (all P<0.05). IOP reductions in the study group were substantially more prominent than in the control group at all postoperative time points (all P<0.05). The complete success rate in the study group was significantly higher than in the control group (71.4% vs. 33.3%, P<0.05), while the complete failure rate was significantly lower in the study group (0% vs. 28.5%, P<0.05). According to Cox’s proportional hazards regression analysis, high IOP at baseline was independently associated with increased risks of complete failure (adjusted hazard ratio=1.141, 95% confidence interval=1.021-1.276, P<0.05). There was no significant difference in the incidence of postoperative complications between the two groups (P>0.05). Conclusion: Both in-situ surgical and needle revision have acceptable success rates and safety for the late failed trabeculectomy blebs, while the former is likely to have a higher level of efficacy over the latter. Needle revision may be insufficient for eyes with low target IOP. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title="glaucoma">glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=trabeculectomy%20blebs" title=" trabeculectomy blebs"> trabeculectomy blebs</a>, <a href="https://publications.waset.org/abstracts/search?q=in-situ%20surgical%20revision" title=" in-situ surgical revision"> in-situ surgical revision</a>, <a href="https://publications.waset.org/abstracts/search?q=needle%20revision" title=" needle revision"> needle revision</a> </p> <a href="https://publications.waset.org/abstracts/151168/efficacy-of-in-situ-surgical-vs-needle-revision-on-late-failed-trabeculectomy-blebs" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/151168.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">84</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">26</span> Xen45 Gel Implant in Open Angle Glaucoma: Efficacy, Safety and Predictors of Outcome</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Fossarello%20Maurizio">Fossarello Maurizio</a>, <a href="https://publications.waset.org/abstracts/search?q=Mattana%20Giorgio"> Mattana Giorgio</a>, <a href="https://publications.waset.org/abstracts/search?q=Tatti%20Filippo."> Tatti Filippo.</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The most widely performed surgical procedure in Open-Angle Glaucoma (OAG) is trabeculectomy. Although this filtering procedure is extremely effective, surgical failure and postoperative complications are reported. Due to the its invasive nature and possible complications, trabeculectomy is usually reserved, in practice, for patients who are refractory to medical and laser therapy. Recently, a number of micro-invasive surgical techniques (MIGS: Micro-Invasive Glaucoma Surgery), have been introduced in clinical practice. They meet the criteria of micro-incisional approach, minimal tissue damage, short surgical time, reliable IOP reduction, extremely high safety profile and rapid post-operative recovery. Xen45 Gel Implant (Allergan, Dublin, Ireland) is one of the MIGS alternatives, and consists in a porcine gelatin tube designed to create an aqueous flow from the anterior chamber to the subconjunctival space, bypassing the resistance of the trabecular meshwork. In this study we report the results of this technique as a favorable option in the treatment of OAG for its benefits in term of efficacy and safety, either alone or in combination with cataract surgery. This is a retrospective, single-center study conducted in consecutive OAG patients, who underwent Xen45 Gel Stent implantation alone or in combination with phacoemulsification, from October 2018 to June 2019. The primary endpoint of the study was to evaluate the reduction of both IOP and number of antiglaucoma medications at 12 months. The secondary endpoint was to correlate filtering bleb morphology evaluated by means of anterior segment OCT with efficacy in IOP lowering and eventual further procedures requirement. Data were recorded on Microsoft Excel and study analysis was performed using Microsoft Excel and SPSS (IBM). Mean values with standard deviations were calculated for IOPs and number of antiglaucoma medications at all points. Kolmogorov-Smirnov test showed that IOP followed a normal distribution at all time, therefore the paired Student’s T test was used to compare baseline and postoperative mean IOP. Correlation between postoperative Day 1 IOP and Month 12 IOP was evaluated using Pearson coefficient. Thirty-six eyes of 36 patients were evaluated. As compared to baseline, mean IOP and the mean number of antiglaucoma medications significantly decreased from 27,33 ± 7,67 mmHg to 16,3 ± 2,89 mmHg (38,8% reduction) and from 2,64 ± 1,39 to 0,42 ± 0,8 (84% reduction), respectively, at 12 months after surgery (both p < 0,001). According to bleb morphology, eyes were divided in uniform group (n=8, 22,2%), subconjunctival separation group (n=5, 13,9%), microcystic multiform group (n=9, 25%) and multiple internal layer group (n=14, 38,9%). Comparing to baseline, there was no significative difference in IOP between the 4 groups at month 12 follow-up visit. Adverse events included bleb function decrease (n=14, 38,9%), hypotony (n=8, 22,2%) and choroidal detachment (n=2, 5,6%). All eyes presenting bleb flattening underwent needling and MMC injection. The higher percentage of patients that required secondary needling was in the uniform group (75%), with a significant difference between the groups (p=0,03). Xen45 gel stent, either alone or in combination with phacoemulsification, provided a significant lowering in both IOP and medical antiglaucoma treatment and an elevated safety profile. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=anterior%20segment%20OCT" title="anterior segment OCT">anterior segment OCT</a>, <a href="https://publications.waset.org/abstracts/search?q=bleb%20morphology" title=" bleb morphology"> bleb morphology</a>, <a href="https://publications.waset.org/abstracts/search?q=micro-invasive%20glaucoma%20surgery" title=" micro-invasive glaucoma surgery"> micro-invasive glaucoma surgery</a>, <a href="https://publications.waset.org/abstracts/search?q=open%20angle%20glaucoma" title=" open angle glaucoma"> open angle glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=Xen45%20gel%20implant" title=" Xen45 gel implant"> Xen45 gel implant</a> </p> <a href="https://publications.waset.org/abstracts/155901/xen45-gel-implant-in-open-angle-glaucoma-efficacy-safety-and-predictors-of-outcome" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/155901.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">141</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">25</span> Action Potential of Lateral Geniculate Neurons at Low Threshold Currents: Simulation Study</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Faris%20Tarlochan">Faris Tarlochan</a>, <a href="https://publications.waset.org/abstracts/search?q=Siva%20Mahesh%20Tangutooru"> Siva Mahesh Tangutooru </a> </p> <p class="card-text"><strong>Abstract:</strong></p> Lateral Geniculate Nucleus (LGN) is the relay center in the visual pathway as it receives most of the input information from retinal ganglion cells (RGC) and sends to visual cortex. Low threshold calcium currents (IT) at the membrane are the unique indicator to characterize this firing functionality of the LGN neurons gained by the RGC input. According to the LGN functional requirements such as functional mapping of RGC to LGN, the morphologies of the LGN neurons were developed. During the neurological disorders like glaucoma, the mapping between RGC and LGN is disconnected and hence stimulating LGN electrically using deep brain electrodes can restore the functionalities of LGN. A computational model was developed for simulating the LGN neurons with three predominant morphologies, each representing different functional mapping of RGC to LGN. The firings of action potentials at LGN neuron due to IT were characterized by varying the stimulation parameters, morphological parameters and orientation. A wide range of stimulation parameters (stimulus amplitude, duration and frequency) represents the various strengths of the electrical stimulation with different morphological parameters (soma size, dendrites size and structure). The orientation (0-1800) of LGN neuron with respect to the stimulating electrode represents the angle at which the extracellular deep brain stimulation towards LGN neuron is performed. A reduced dendrite structure was used in the model using Bush–Sejnowski algorithm to decrease the computational time while conserving its input resistance and total surface area. The major finding is that an input potential of 0.4 V is required to produce the action potential in the LGN neuron which is placed at 100 µm distance from the electrode. From this study, it can be concluded that the neuroprostheses under design would need to consider the capability of inducing at least 0.4V to produce action potentials in LGN. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=Lateral%20Geniculate%20Nucleus" title="Lateral Geniculate Nucleus">Lateral Geniculate Nucleus</a>, <a href="https://publications.waset.org/abstracts/search?q=visual%20cortex" title=" visual cortex"> visual cortex</a>, <a href="https://publications.waset.org/abstracts/search?q=finite%20element" title=" finite element"> finite element</a>, <a href="https://publications.waset.org/abstracts/search?q=glaucoma" title=" glaucoma"> glaucoma</a>, <a href="https://publications.waset.org/abstracts/search?q=neuroprostheses" title=" neuroprostheses"> neuroprostheses</a> </p> <a href="https://publications.waset.org/abstracts/38655/action-potential-of-lateral-geniculate-neurons-at-low-threshold-currents-simulation-study" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/38655.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">277</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">24</span> Ophthalmic Self-Medication Practices and Associated Factors among Adult Ophthalmic Patients</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Sarah%20Saad%20Alamer">Sarah Saad Alamer</a>, <a href="https://publications.waset.org/abstracts/search?q=Shujon%20Mohammed%20Alazzam"> Shujon Mohammed Alazzam</a>, <a href="https://publications.waset.org/abstracts/search?q=Amjad%20Khater%20Alanazi"> Amjad Khater Alanazi</a>, <a href="https://publications.waset.org/abstracts/search?q=Mohamed%20Ahmed%20Sankari"> Mohamed Ahmed Sankari</a>, <a href="https://publications.waset.org/abstracts/search?q=Jana%20Sameer%20Sendy"> Jana Sameer Sendy</a>, <a href="https://publications.waset.org/abstracts/search?q=Saleh%20Al-Khaldi"> Saleh Al-Khaldi</a>, <a href="https://publications.waset.org/abstracts/search?q=Khaled%20Allam"> Khaled Allam</a>, <a href="https://publications.waset.org/abstracts/search?q=Amani%20Badawi"> Amani Badawi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: Self-medication is defined as the selection of medicines by individuals to treat self-diagnosed. There are a lot of concerns about the safety of long-term use of nonprescription ophthalmic drugs, which may lead to a variety of serious ocular complications. Topical steroids can produce severe eye-threatening complications, including the elevation of intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage. In recent times, many OTC ophthalmic preparations have been possible without a prescription. Objective: In our study, we aimed to determine the prevalence of self-medication ocular topical steroid practice and associated factors among adult ophthalmic patients attending King Saud medical city. Methods: This study was conducted as a cross-sectional study, targeting participants aged 18 years old or above who had used topical steroids eye drops to determine the prevalence of self-medication ocular topical steroid practice and associated factors among adult patients attending ophthalmology clinic in King Saud Medical City (KSMC) in the central region. Results: A total of 308 responses, 92(29.8%) were using ocular topical, 58(18.8%) with prescription, 5(1.6%) without prescription, 29(9.4%) with and without prescription while 216(70.1%) did not use it. The frequency of using ocular topical steroids without a prescription among participants was 11(12%) once and 33 (35%) many times. 26(28.3%) were having complication, mostly 11(12.4%) eye infection, 8(9%) Glaucoma, 6 (6.7%) Cataracts. Reasons for self-medication ocular topical steroid practice among participants were 14 (15.2%) repeated symptoms, 11(15.2%) had heard an advice from a friend, 11 (15.2%) thought they had enough knowledge. Conclusion: Our study reveals that, even though detecting a high level of knowledge and acceptable practices and attitudes among participants, the incidence of self-medication with steroid eye drops was observed. This practice is mainly due to participants having repeated symptoms and thinking they have enough knowledge. Increasing the education level of patients on self-medication steroid eye drops practice and it is associated complications would help reduce the incidence of self-medication steroid eye drops practice. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=self-medication" title="self-medication">self-medication</a>, <a href="https://publications.waset.org/abstracts/search?q=ophthalmic%20medicine" title=" ophthalmic medicine"> ophthalmic medicine</a>, <a href="https://publications.waset.org/abstracts/search?q=steroid%20eye%20drop" title=" steroid eye drop"> steroid eye drop</a>, <a href="https://publications.waset.org/abstracts/search?q=over%20the%20counter" title=" over the counter"> over the counter</a> </p> <a href="https://publications.waset.org/abstracts/163122/ophthalmic-self-medication-practices-and-associated-factors-among-adult-ophthalmic-patients" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/163122.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">89</span> </span> </div> </div> <ul class="pagination"> <li class="page-item disabled"><span class="page-link">&lsaquo;</span></li> <li class="page-item active"><span class="page-link">1</span></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=glaucoma&page=2">2</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=glaucoma&page=2" rel="next">&rsaquo;</a></li> </ul> </div> </main> <footer> <div id="infolinks" class="pt-3 pb-2"> <div class="container"> <div style="background-color:#f5f5f5;" class="p-3"> <div class="row"> <div class="col-md-2"> <ul class="list-unstyled"> About <li><a href="https://waset.org/page/support">About Us</a></li> <li><a href="https://waset.org/page/support#legal-information">Legal</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/WASET-16th-foundational-anniversary.pdf">WASET celebrates its 16th foundational anniversary</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Account <li><a href="https://waset.org/profile">My Account</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Explore <li><a href="https://waset.org/disciplines">Disciplines</a></li> <li><a href="https://waset.org/conferences">Conferences</a></li> <li><a href="https://waset.org/conference-programs">Conference Program</a></li> <li><a href="https://waset.org/committees">Committees</a></li> <li><a href="https://publications.waset.org">Publications</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Research <li><a href="https://publications.waset.org/abstracts">Abstracts</a></li> <li><a href="https://publications.waset.org">Periodicals</a></li> <li><a href="https://publications.waset.org/archive">Archive</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Open Science <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Science-Philosophy.pdf">Open Science Philosophy</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Science-Award.pdf">Open Science Award</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Society-Open-Science-and-Open-Innovation.pdf">Open Innovation</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Postdoctoral-Fellowship-Award.pdf">Postdoctoral Fellowship Award</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Scholarly-Research-Review.pdf">Scholarly Research Review</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Support <li><a href="https://waset.org/page/support">Support</a></li> <li><a href="https://waset.org/profile/messages/create">Contact Us</a></li> <li><a href="https://waset.org/profile/messages/create">Report Abuse</a></li> </ul> </div> </div> </div> </div> </div> <div class="container text-center"> <hr style="margin-top:0;margin-bottom:.3rem;"> <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank" class="text-muted small">Creative Commons Attribution 4.0 International License</a> <div id="copy" class="mt-2">© 2024 World Academy of Science, Engineering and Technology</div> </div> </footer> <a href="javascript:" id="return-to-top"><i class="fas fa-arrow-up"></i></a> <div class="modal" id="modal-template"> <div class="modal-dialog"> <div class="modal-content"> <div class="row m-0 mt-1"> <div class="col-md-12"> <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">×</span></button> </div> </div> <div class="modal-body"></div> </div> </div> </div> <script src="https://cdn.waset.org/static/plugins/jquery-3.3.1.min.js"></script> <script src="https://cdn.waset.org/static/plugins/bootstrap-4.2.1/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.waset.org/static/js/site.js?v=150220211556"></script> <script> jQuery(document).ready(function() { /*jQuery.get("https://publications.waset.org/xhr/user-menu", function (response) { jQuery('#mainNavMenu').append(response); });*/ jQuery.get({ url: "https://publications.waset.org/xhr/user-menu", cache: false }).then(function(response){ jQuery('#mainNavMenu').append(response); }); }); </script> </body> </html>